National Science Library of Georgia

Medication-induced movement disorders / (Record no. 516101)

MARC details
000 -LEADER
fixed length control field 03661nam a22003498i 4500
001 - CONTROL NUMBER
control field CR9781107588738
003 - CONTROL NUMBER IDENTIFIER
control field UkCbUP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200124160214.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m|||||o||d||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 131007s2015||||enk o ||1 0|eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781107588738 (ebook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781107066007 (hardback)
040 ## - CATALOGING SOURCE
Original cataloging agency UkCbUP
Language of cataloging eng
Description conventions rda
Transcribing agency UkCbUP
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC376.5
Item number .M44 2015
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.8/3
Edition number 23
245 00 - TITLE STATEMENT
Title Medication-induced movement disorders /
Statement of responsibility, etc edited by Joseph H. Friedman, Butler Hospital and Department of Neurology at the Alpert Medical School of Brown University, Providence, RI, and School of Pharmacy at the University of Rhode Island, Kingston, RI, USA.
264 #1 - Production, Publication, Distribution, Manufacture, and Copyright Notice (R)
Place of production, publication, distribution, manufacture (R) Cambridge :
Name of producer, publisher, distributor, manufacturer (R) Cambridge University Press,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (ix, 197 pages) :
Other physical details digital, PDF file(s).
336 ## - Content Type (R)
Content type term (R) text
Content type code (R) txt
Source (NR) rdacontent
337 ## - Media Type (R)
Media type term (R) computer
Media type code (R) c
Source (NR) rdamedia
338 ## - Carrier Type (R)
Carrier type term (R) online resource
Carrier type code (R) cr
Source (NR) rdacarrier
500 ## - GENERAL NOTE
General note Title from publisher's bibliographic system (viewed on 05 Oct 2015).
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Machine generated contents note: List of contributors; Dedication; Introduction; 1. Acute akathisia Drew S. Kern and Anthony E. Lang; 2. Acute dystonia Anne Marthe Meppelink and Mark J. Edwards; 3. Neuroleptic malignant syndrome Atbin Djamashidian and Sean S. O'Sullivan; 4. Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez; 5. Neuroleptic Parkinsonism Joseph H. Friedman; 6. Tardive syndromes Daniel Tarsy and Raminder Parihar; 7. Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan and Theresa A. Zesiewicz; 8. Atypical antipsychotics and movement disorders Rob M. A. de Bie; 9. Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew; 10. Medication-induced tremors Peter A. Lewitt; 11. L-Dopa dyskinesias Juan Ramirez-Castaneda and Joseph Jankovic; 12. VPA, lithium, amiodarone and other non-DA Michael Silver and Stewart A. Factor; 13. Anti-depressants and movement disorders Gilles Fe;nelon; 14. Ataxia Marina Sanchez Abraham and Oscar S. Gershanik; 15. Myoclonus and asterixis P. D. Thompson, T. J. Kleinig and T. E. Kimber; 16. Imaging in medication-induced Parkinsonism Danna Jennings; 17. Deep brain stimulation for Tardive disorders Bernardo Rodrigues and Kelvin L. Chou; Index.
520 ## - SUMMARY, ETC.
Summary, etc Medications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood-brain barrier.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Movement disorders
General subdivision Etiology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Movement disorders.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Movement disorders
General subdivision Treatment.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Friedman, Joseph H.,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
International Standard Book Number 9781107066007
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1017/CBO9781107588738">https://doi.org/10.1017/CBO9781107588738</a>

No items available.

Copyright © 2023 Sciencelib.ge All rights reserved.